Cfs Investment Advisory Services, LLC Biogen Inc. Transaction History

Cfs Investment Advisory Services, LLC

  • $1.23 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022
BUY
$194.69 - $268.46 $4 Million - $5.52 Million
20,559 New
20,559 $0
Q2 2022

Aug 16, 2022
SELL
$187.54 - $223.02 $1.97 Million - $2.35 Million
-10,530 Closed
0 $0
Q1 2022

May 27, 2022
BUY
$193.77 - $244.14 $2.04 Million - $2.57 Million
10,530 New
10,530 $0

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cfs Investment Advisory Services, LLC Portfolio

Follow Cfs Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfs Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfs Investment Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email